Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Cerapedics brings in $11mm via Series D

Executive Summary

Orthobiologics firm Cerapedics Inc. raised $11mm in its Series D financing. According to the Form D, eight investors participated and the company could bring in another $3mm in the round. Some proceeds will fund ongoing US commercialization of its i-FACTOR peptide-enhanced bone graft for use in anterior cervical discectomy and fusion procedures in patients with degenerative cervical disc disease. Cerapedics will use additional money to develop its P-15 synthetic small-peptide technology for lumbar spine fusion.
Deal Industry
  • Biotechnology
    • Large Molecule
  • Medical Devices
    • Biomaterials
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies